Doctors treat deadly cancerous disorders with gene-guided, targeted therapy

(Cincinnati Children's Hospital Medical Center) Genomic testing of biopsies from patients with deadly, treatment-resistant cancerous blood syndromes called histiocytoses allowed doctors to identify genes fueling the ailments and use targeted molecular drugs to successfully treat them. Researchers report their data in Journal of Clinical Investigation Insight (JCI Insight). They recommend the regular use of comprehensive genomic profiling at diagnosis to positively impact clinical care.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news